サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1541699

IV（静脈内）投与イブプロフェン市場レポート：製品用量、適応症、年齢層、地域別、2024～2032年

Intravenous (IV) Ibuprofen Market Report by Product Dose (100 Mg Dose, 200 Mg Dose, 400 Mg Dose, 800 Mg Dose), Indication (Pain/Inflammatory, Fever), Age Group (Pediatrics, Adults), and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 139 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
IV（静脈内）投与イブプロフェン市場レポート：製品用量、適応症、年齢層、地域別、2024～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 139 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のIV（静脈内）投与イブプロフェン市場規模は2023年に68億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに126億米ドルに達し、2024～2032年の間に6.79%の成長率（CAGR）を示すと予測しています。

イブプロフェンは非ステロイド性抗炎症薬（NSAID）に属し、炎症、疼痛、発熱の治療に使用されます。プロスタグランジン（PG）の合成に必要なシクロオキシゲナーゼCOZ-1とCOX-2酵素を阻害します。イブプロフェンの静脈内注射は、軽度から重度の不快感を和らげるために単独で、または他の薬と一緒に使用されます。イブプロフェンを静脈内に直接注射することで、炎症を引き起こす特定の天然物質が体内で産生されるのを阻害します。麻薬性鎮痛薬の必要量を減らし、優れた安全性プロファイルで痛みのレベルを下げるのに役立ちます。また、イブプロフェンの静脈内投与は、整形外科手術や腹部手術、発熱時の疼痛コントロールを改善し、オピオイド製剤の使用量を減らすのに役立ちます。

IV（静脈内）投与イブプロフェン市場動向

高齢者人口が着実に増加し、世界中で関節炎、心血管疾患（CVDs）、がんの有病率が増加していることが、市場に明るい展望をもたらしています。これに伴い、炎症性疾患、リウマチ性疾患、軽度から中等度の疼痛、発熱、月経困難症、変形性関節症の管理・治療のための製品採用が広がっており、市場の成長に好影響を与えています。さらに、多忙な勤務スケジュールや不健康なライフスタイル、それに伴う身体活動や適切な栄養摂取の減少が、慢性疾患の発生率の上昇につながっており、これがもう一つの成長促進要因として作用しています。これとは別に、軽度の発熱、歯の痛み、胃腸の痛み、小児科における動脈管開存の治療への製品利用が増加していることも、市場成長に弾みをつけています。さらに、点滴イブプロフェンは筋肉痛やリウマチ痛、腰痛、神経痛、捻挫、挫傷、スポーツ外傷、筋骨格系疾患の緩和にも使用され、市場成長を促進しています。さらに、膝や股関節の置換手術後の整形外科患者において、疼痛やモルヒネの使用を軽減するためにイブプロフェンの静脈内投与に対する需要が増加していることも、市場成長にプラスの影響を与えています。その他の要因としては、医療インフラの大幅な改善、個人の健康意識の高まり、消費者の支出能力の上昇などが挙げられ、市場成長の原動力になると予想されます。

本レポートで扱う主要質問

  • 2023年の世界のIV（静脈内）投与イブプロフェン市場の市場規模は？
  • 2024～2032年の世界のIV（静脈内）投与イブプロフェン市場の予想成長率は？
  • 世界のIV（静脈内）投与イブプロフェン市場を牽引する主要因は何か？
  • 世界のIV（静脈内）投与イブプロフェン市場に対するCOVID-19の影響は？
  • IV（静脈内）投与イブプロフェン市場の世界における適応症別内訳は？
  • 世界のIV（静脈内）投与イブプロフェン市場の年齢層別内訳は？
  • IV（静脈内）投与イブプロフェン市場の世界における主要地域は？
  • 世界のIV（静脈内）投与イブプロフェン市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のIV（静脈内）投与イブプロフェン市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品用量別

  • 100mg
  • 200mg
  • 400mg
  • 800mg

第7章 市場内訳：適応症別

  • 痛み/炎症
  • 熱

第8章 市場内訳：年齢層別

  • 小児
  • 成人

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Cumberland Pharmaceuticals Inc.
    • Hyloris Pharmaceuticals SA
    • Recordati Rare Diseases Inc.
    • VALMOR Laboratories CA
    • Xgen Pharmaceuticals Djb Inc.
図表

List of Figures

  • Figure 1: Global: Intravenous Ibuprofen Market: Major Drivers and Challenges
  • Figure 2: Global: Intravenous Ibuprofen Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Intravenous Ibuprofen Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Intravenous Ibuprofen Market: Breakup by Product Dose (in %), 2023
  • Figure 5: Global: Intravenous Ibuprofen Market: Breakup by Indication (in %), 2023
  • Figure 6: Global: Intravenous Ibuprofen Market: Breakup by Age Group (in %), 2023
  • Figure 7: Global: Intravenous Ibuprofen Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Intravenous Ibuprofen (100 Mg Dose) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Intravenous Ibuprofen (100 Mg Dose) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Intravenous Ibuprofen (200 Mg Dose) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Intravenous Ibuprofen (200 Mg Dose) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Intravenous Ibuprofen (400 Mg Dose) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Intravenous Ibuprofen (400 Mg Dose) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Intravenous Ibuprofen (800 Mg Dose) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Intravenous Ibuprofen (800 Mg Dose) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Intravenous Ibuprofen (Pain/Inflammatory) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Intravenous Ibuprofen (Pain/Inflammatory) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Intravenous Ibuprofen (Fever) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Intravenous Ibuprofen (Fever) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Intravenous Ibuprofen (Pediatrics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Intravenous Ibuprofen (Pediatrics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Intravenous Ibuprofen (Adults) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Intravenous Ibuprofen (Adults) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: North America: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: North America: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: United States: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: United States: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Canada: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Canada: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Asia-Pacific: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Asia-Pacific: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: China: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: China: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Japan: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Japan: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: India: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: India: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: South Korea: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: South Korea: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Australia: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Australia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Indonesia: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Indonesia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Others: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Europe: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Europe: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Germany: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Germany: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: France: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: France: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: United Kingdom: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: United Kingdom: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Italy: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Italy: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Spain: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Spain: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Russia: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Russia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Latin America: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Latin America: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Brazil: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Brazil: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Mexico: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Mexico: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Middle East and Africa: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Middle East and Africa: Intravenous Ibuprofen Market: Breakup by Country (in %), 2023
  • Figure 72: Middle East and Africa: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Global: Intravenous Ibuprofen Industry: SWOT Analysis
  • Figure 74: Global: Intravenous Ibuprofen Industry: Value Chain Analysis
  • Figure 75: Global: Intravenous Ibuprofen Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Intravenous Ibuprofen Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Intravenous Ibuprofen Market Forecast: Breakup by Product Dose (in Million US$), 2024-2032
  • Table 3: Global: Intravenous Ibuprofen Market Forecast: Breakup by Indication (in Million US$), 2024-2032
  • Table 4: Global: Intravenous Ibuprofen Market Forecast: Breakup by Age Group (in Million US$), 2024-2032
  • Table 5: Global: Intravenous Ibuprofen Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Intravenous Ibuprofen Market: Competitive Structure
  • Table 7: Global: Intravenous Ibuprofen Market: Key Players
目次
Product Code: SR112024A6440

The global intravenous (IV) ibuprofen market size reached US$ 6.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.6 Billion by 2032, exhibiting a growth rate (CAGR) of 6.79% during 2024-2032.

Ibuprofen belongs to the nonsteroidal anti-inflammatory drug (NSAID) class used to treat inflammation, pain, and fever. It inhibits cyclooxygenase COZ-1 and COX-2 enzymes that are required for the synthesis of prostaglandins (PG). Intravenous (IV) ibuprofen is used alone or with other medicines to relieve mild to severe discomfort. It is injected directly into the vein to block the body's production of certain natural substances that cause inflammation. It helps to reduce narcotic analgesic requirements and lower pain levels with an excellent safety profile. IV ibuprofen also aids in improving pain control and reducing the usage of opioid drugs in orthopedic and abdominal surgeries and fever.

Intravenous (IV) Ibuprofen Market Trends:

The steadily rising geriatric population and the increasing prevalence of arthritis, cardiovascular diseases (CVDs), and cancer across the globe are creating a positive outlook for the market. In line with this, the widespread product adoption to manage and treat inflammatory diseases, rheumatoid disorders, mild to moderate pain, fever, dysmenorrhea, and osteoarthritis is favoring the market growth. Moreover, hectic working schedules and unhealthy lifestyles, along with a consequent decline in physical activity and proper nutrition, have led to a rise in the incidences of chronic diseases, which is acting as another growth-inducing factor. Apart from this, the increasing product utilization to treat mild fever, dental pain, gastrointestinal pain, and ductus arteriosus in pediatrics is providing an impetus to the market growth. Moreover, IV ibuprofen is employed to relieve muscle or rheumatic pain, backache, neuralgia, sprains, strains, sports injuries, and musculoskeletal diseases, which is facilitating the market growth. Furthermore, the increasing demand for IV ibuprofen in orthopedic patients post knee or hip replacement surgeries to reduce pain and morphine use is positively influencing the market growth. Other factors, including significant improvements in the healthcare infrastructure, growing health consciousness among individuals, and the rising expenditure capacities of consumers, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global intravenous (IV) ibuprofen market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product dose, indication and age group.

Breakup by Product Dose:

100 Mg Dose

200 Mg Dose

400 Mg Dose

800 Mg Dose

Breakup by Indication:

Pain/Inflammatory

Fever

Breakup by Age Group:

Pediatrics

Adults

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Cumberland Pharmaceuticals Inc., Hyloris Pharmaceuticals SA, Recordati Rare Diseases Inc., VALMOR Laboratories CA and Xgen Pharmaceuticals Djb Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global Intravenous (IV) ibuprofen market in 2023?
  • 2. What is the expected growth rate of the global Intravenous (IV) ibuprofen market during 2024-2032?
  • 3. What are the key factors driving the global Intravenous (IV) ibuprofen market?
  • 4. What has been the impact of COVID-19 on the global Intravenous (IV) ibuprofen market?
  • 5. What is the breakup of the global Intravenous (IV) ibuprofen market based on the indication?
  • 6. What is the breakup of the global Intravenous (IV) ibuprofen market based on the age group?
  • 7. What are the key regions in the global Intravenous (IV) ibuprofen market?
  • 8. Who are the key players/companies in the global Intravenous (IV) ibuprofen market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Intravenous (IV) Ibuprofen Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Dose

  • 6.1 100 Mg Dose
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 200 Mg Dose
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 400 Mg Dose
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 800 Mg Dose
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Pain/Inflammatory
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Fever
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Age Group

  • 8.1 Pediatrics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Adults
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Cumberland Pharmaceuticals Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Hyloris Pharmaceuticals SA
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Recordati Rare Diseases Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 VALMOR Laboratories CA
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Xgen Pharmaceuticals Djb Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio